science
Ozempic delivers major weight loss in adults over 65, study finds
Why this matters: new research or scientific developments with potential real-world impact.
A major new analysis suggests semaglutide (Ozempic, Wegovy) works remarkably well in adults over 65, helping many lose substantial amounts of weight while improving heart and metabolic health. Participants taking the drug lost over 15% of their body weight on average — far more than those receiving
Read full story on Science Daily → More top storiesAlso covered by
Aggregated and edited by the Scoop newsroom. We surface news from Science Daily alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop